Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.
about
Soluble receptor for advanced glycation end-products and progression of airway diseaseReceptor for advanced glycation end-products regulates lung fluid balance via protein kinase C-gp91(phox) signaling to epithelial sodium channels.B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review.Advanced glycation endproducts and their receptor in different body compartments in COPDAssociation of plasma sRAGE, but not esRAGE with lung function impairment in COPD.Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokersClinical use of high mobility group box 1 and the receptor for advanced glycation end products in the prognosis and risk stratification of heart failure: a literature review.Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation.Receptor for advanced glycation end products and soluble receptor for advanced glycation end products: a balancing act in chronic obstructive pulmonary disease?Research update for articles published in EJCI in 2012Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
P2860
Q33613288-81D02FBE-8DD3-4F3D-970B-735FC2043425Q33756371-32EF344A-B95E-4E12-A68A-08FC5426B8D7Q36245755-F2C4DF0A-6CA6-4037-B6F0-BE90D123422AQ36842527-035FE29D-B9D5-46AE-8BB3-F9BE9A3172E1Q37620204-60FAB453-18DA-480D-8C48-7FAADF8F2651Q38541559-4D53D52D-2175-41E9-9B4B-D20529EE4679Q38620860-A56A1968-DF8B-4592-A14F-8787DF1121A3Q38661408-D0AA67D1-5EDC-4F14-BD76-44FC08A22F4FQ39018507-BC58F1A3-5FA8-41F2-ABAE-C330529588B1Q45339625-67885DD5-D1FD-40D2-8178-E56DB4B74F4AQ54757715-ADA6C202-D524-4B24-99D1-401511B5A638Q57913380-7E9F1AFE-EC1A-4A85-AAC9-0C030D8B2DACQ58564998-013C0707-DCF4-4BFF-AFD9-7B6F5580C8E6
P2860
Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Plasma sRAGE and N-
@nl
Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.
@en
type
label
Plasma sRAGE and N-
@nl
Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.
@en
prefLabel
Plasma sRAGE and N-
@nl
Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.
@en
P2093
P2860
P50
P356
P1476
Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.
@en
P2093
Alessandro Fucili
Alfredo Potena
Enrico Casimirri
Licia Ballerin
Marina Gorrini
Maurizio Luisetti
Piera Boschetto
P2860
P304
P356
10.1111/ECI.12079
P577
2013-04-17T00:00:00Z